Primary Site >> Colorectal Cancer

Gene >> ARID1A

  • 1991
  • 1995
  • 1996
  • 1999
  • 2002
  • 2004
  • 2007
  • 2012
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas.
PMID: 1909869
Ref: Feasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 steps targetting with bispecific antibody.
PMID: 7571036
Ref: Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
PMID: 7796413
Ref: Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
PMID: 8616751
Ref: Cellular immunotherapy for patients with metastatic colorectal carcinoma using lymph node lymphocytes localized in vivo by radiolabeled monoclonal antibody.
PMID: 10391559
Ref: [The detection of sentinel lymph node in nuclear medicine].
PMID: 12206980
Ref: Low-volume jet injection for efficient nonviral in vivo gene transfer.
PMID: 15477651
Ref: (124)I-Labeled humanized CH2-domain-deleted anti-tumor-associated glycoprotein-72 (TAG-72) monoclonal antibody
PMID: 22049576
Ref: The cancer incidence temporality index: an index to show temporal changes in the age of onset of overall and specific cancer (England and Wales, 1971-1999).
PMID: 17582728
Ref: Comprehensive molecular characterization of human colon and rectal cancer.
PMID: 22810696
Ref: Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
PMID: 24382590
Ref: Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
PMID: 24494971
Ref: Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
PMID: 24599305
Ref: Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
PMID: 24755471
Ref: Decreased ARID1A expression facilitates cell proliferation and inhibits 5-fluorouracil-induced apoptosis in colorectal carcinoma.
PMID: 24833095
Ref: Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency.
PMID: 24925223
Ref: Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
PMID: 25311944
Ref: Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.
PMID: 25561809
Ref: Epigenetic and genetic dispositions of ovarian carcinomas.
PMID: 25594067
Ref: Loss of AT-rich interactive domain 1A expression in gastrointestinal malignancies.
PMID: 25503393
Ref: Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.
PMID: 25695927
Ref: Microsatellite instability: an update.
PMID: 25701956
Ref: Randomized Controlled Trial of Shared Care for Patients With Cancer Involving General Practitioners and Cancer Specialists.
PMID: 25758448
Ref: Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer.
PMID: 26243311
Ref: Fluorescence-Guided Surgery of Liver Metastasis in Orthotopic Nude-Mouse Models.
PMID: 26427050
Ref: ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
PMID: 26980037
Ref: Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/beta-catenin signaling pathway mutations.
PMID: 26998897
Ref: Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
PMID: 27001432
Ref: ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice.
PMID: 27941798
Ref: The shifting epidemiology of colorectal cancer in sub-Saharan Africa.
PMID: 28397702
Ref: Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas.
PMID: 28440661
Ref: Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
PMID: 28524162
Ref: Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysis.
PMID: 28937020
Ref: Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
PMID: 28967863
Ref: Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations.
PMID: 29296220
Ref: Phosphatidylinositol 3-Kinase alpha-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study.
PMID: 29401002
Ref: Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses.
PMID: 29793804
Ref: Aneuploidy of chromosome 8 and mutation of circulating tumor cells predict pathologic complete response in the treatment of locally advanced rectal cancer.
PMID: 30008877
Ref: Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells.
PMID: 30097580
Ref: Quantitative analysis of somatically-acquired and constitutive uniparental disomy in gastrointestinal cancers.
PMID: 30350313
Ref: DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
PMID: 30381262